446 related articles for article (PubMed ID: 14871421)
21. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in chronic kidney disease.
Modaresi A; Nafar M; Sahraei Z
Iran J Kidney Dis; 2015 May; 9(3):165-79. PubMed ID: 25957419
[TBL] [Abstract][Full Text] [Related]
23. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].
Font R; Prats M; Gutiérrez C; Bardají A; Lalana M; Marsillach J; Camps J; Martínez Vea A
Nefrologia; 2009; 29(3):228-35. PubMed ID: 19554056
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
[TBL] [Abstract][Full Text] [Related]
25. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
[TBL] [Abstract][Full Text] [Related]
26. Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age.
Carter JL; Stevens PE; Irving JE; Lamb EJ
QJM; 2011 Oct; 104(10):839-47. PubMed ID: 21652537
[TBL] [Abstract][Full Text] [Related]
27. Chronic kidney disease in prevalent orthotopic heart transplant recipients using a new CKD-EPI formula.
Przybylowski P; Malyszko J; Malyszko J
Ann Transplant; 2010; 15(1):32-5. PubMed ID: 20305315
[TBL] [Abstract][Full Text] [Related]
28. [Predictors of chronic kidney disease in hypertensive patients].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Jul; 25(145):9-14. PubMed ID: 18839606
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
White SL; Polkinghorne KR; Atkins RC; Chadban SJ
Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
[TBL] [Abstract][Full Text] [Related]
30. Endothelial function, CRP and oxidative stress in chronic kidney disease.
Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of chronic kidney disease is extremely high in heart transplant recipients.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2009 Oct; 41(8):3239-41. PubMed ID: 19857720
[TBL] [Abstract][Full Text] [Related]
32. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.
Karamouzis I; Sarafidis PA; Karamouzis M; Iliadis S; Haidich AB; Sioulis A; Triantos A; Vavatsi-Christaki N; Grekas DM
Am J Nephrol; 2008; 28(3):397-404. PubMed ID: 18063858
[TBL] [Abstract][Full Text] [Related]
33. Vascular disease and chronic renal failure: new insights.
Nanayakkara PW; Gaillard CA
Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD.
Ramos LF; Shintani A; Ikizler TA; Himmelfarb J
J Am Soc Nephrol; 2008 Mar; 19(3):593-9. PubMed ID: 18256365
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
[TBL] [Abstract][Full Text] [Related]
36. [Inflammation, oxidative stress and kidney function in arterial hypertension].
Cerasola G; Guarneri M; Cottone S
G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
[TBL] [Abstract][Full Text] [Related]
37. Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness.
Yong K; Ooi EM; Dogra G; Mannion M; Boudville N; Chan D; Lim EM; Lim WH
Cytokine; 2013 Oct; 64(1):39-42. PubMed ID: 23778029
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
[TBL] [Abstract][Full Text] [Related]
39. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
[TBL] [Abstract][Full Text] [Related]
40. The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients.
Turkmen K; Tonbul HZ; Toker A; Gaipov A; Erdur FM; Cicekler H; Anil M; Ozbek O; Selcuk NY; Yeksan M; Turk S
Ren Fail; 2012; 34(10):1229-37. PubMed ID: 23025491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
